|
ZFHX3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.590330E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.983800E-03 |
| Normal-vs-Stage2 |
2.836100E-02 |
| Normal-vs-Stage3 |
7.53119999999941E-05 |
| Normal-vs-Stage4 |
1.27980000041994E-07 |
| Stage1-vs-Stage2 |
8.744200E-01 |
| Stage1-vs-Stage3 |
1.496620E-01 |
| Stage1-vs-Stage4 |
2.156200E-04 |
| Stage2-vs-Stage3 |
2.341400E-01 |
| Stage2-vs-Stage4 |
9.155700E-03 |
| Stage3-vs-Stage4 |
3.884200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.188100E-04 |
| Normal-vs-AfricanAmerican |
1.461970E-01 |
| Normal-vs-Asian |
1.482320E-03 |
| Caucasian-vs-AfricanAmerican |
3.478800E-01 |
| Caucasian-vs-Asian |
7.230400E-01 |
| AfricanAmerican-vs-Asian |
2.656600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.245600E-04 |
| Normal-vs-Female |
3.962500E-04 |
| Male-vs-Female |
6.656600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.805000E-03 |
| Normal-vs-Age(41-60Yrs) |
5.599000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.55058999999902E-05 |
| Normal-vs-Age(81-100Yrs) |
9.957100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.541800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.694100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.867620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.311040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.779000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.644200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.7839000000024E-05 |
| Classical-VS-Follicular |
4.481900E-02 |
| Classical-VS-Other |
1.403610E-01 |
| Classical-VS-Normal |
4.762800E-03 |
| Tall-VS-Follicular |
8.711800E-02 |
| Tall-VS-Other |
9.639000E-01 |
| Tall-VS-Normal |
3.95249999951552E-07 |
| Follicular-VS-Other |
4.771000E-01 |
| Follicular-VS-Normal |
4.154800E-04 |
| Other-VS-Normal |
1.433870E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.844000E-04 |
| Normal-vs-N1 |
1.581100E-04 |
| N0-vs-N1 |
3.436800E-01 |
|
|
